Insuline medical is developing technologies and products to improve and manage subcutaneous drug delivery, especially for patients on injection therapy. The company has developed the EyePen, a diabetes management system intended for use by diabetic patients on insulin injection therapy. The EyePen system includes a smart add-on to insulin injection pens which tracks pen activity and transmits the data to a diabetes management app. The app use the insulin data along with blood-glucose data to help patients manage their disease.